Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter studyFumihiko Urabe, Takahiro Kimura, Kosuke Iwatani et al.|Japanese Journal of Clinical Oncology|2024Cited by 22
Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter studyFumihiko Urabe, Katsuki Muramoto, Takafumi Yanagisawa et al.|International Journal of Urology|2024Cited by 20
Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched CohortTatsuya Shimomura, Fumihiko Urabe, Katsuki Muramoto et al.|The Prostate|2025Cited by 3
Predicting pathological upstaging after radical nephroureterectomy in patients with upper tract urothelial carcinoma: results from a multicenter cohort studyFumihiko Urabe, R. Yamaguchi, Hirokazu Kagawa et al.|Translational Andrology and Urology|2024Cited by 1
Novel Preoperative Immune Prognostic Index for Predicting Outcomes in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaKen Shibata, Fumihiko Urabe, Kosuke Iwatani et al.|In Vivo|2025Cited by 1